DSP Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1208 Cr | ₹3198 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 28 Dec 2015 | 30 Nov 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare |
Turn Over | 26.49% | 18% |
Expense Ratio | 2.14 | 1.9 |
Manager | Meeta Shetty | Jay Kothari |
ISIN Code | INF277K016A9 | INF740KA1LD8 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Month | 0.85% | -1.2% |
6 Month | -0.98% | -9.29% |
1 Year | 14.18% | 12.21% |
3 Year | 22.45% | 22.35% |
5 Year | 21.82% | 23.63% |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
6 Month | 2.02% | -4.18% |
1 Year | 3.65% | -6.66% |
3 Year | 24.44% | 21.28% |
5 Year | 19.76% | 18.29% |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Year | 7.82% | 28.82% |
3 Year | 17.79% | 20.72% |
5 Year | 14.55% | 27.72% |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Standard Deviation | 16.538% | 15.905% |
Sharp | 0.681% | 0.799% |
Beta | 0.969% | 0.897% |
Alpha | 0.018% | 2.271% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Name | Meeta Shetty | Jay Kothari |
Total AUM | ₹17847 Cr | ₹0 Cr |
Funds Managed | 5 | 20 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 5.06 | 18.5 |
Small Cap | 27.82 | 49.08 |
Large Cap | 35.26 | 18.51 |
Mid Cap | 31.87 | 13.9 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 4.34 | 1.47 |
Basic Materials | 2.22 | - |
Healthcare | 93.44 | 97.13 |
Financial Services | - | 1.4 |
Top Comparisons
Aditya Birla Sun Life Bal Bhavishya Yojna Regular Growth
3Y Returns15.87%
LIC MF Children's Gift Fund-Growth
3Y Returns13.06%
ICICI Prudential Medium Term Bond Fund - Growth
3Y Returns8.02%
Invesco India Medium Duration Fund - Regular - Growth
3Y Returns7.37%
INVESCO INDIA AGGRESSIVE HYBRID FUND - Regular Plan - Growth
3Y Returns18.61%
LIC MF Equity Hybrid Fund-Growth
3Y Returns14.87%
ITI Value Fund Regular - Growth
3Y Returns21.36%
Nippon India Value Fund- Growth Plan
3Y Returns24.67%